
Susan T. Tran
Examiner (ID: 18781, Phone: (571)272-0606 , Office: P/1615 )
| Most Active Art Unit | 1615 |
| Art Unit(s) | 1618, 1615 |
| Total Applications | 1942 |
| Issued Applications | 1080 |
| Pending Applications | 218 |
| Abandoned Applications | 663 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19316666
[patent_doc_number] => 20240238206
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-18
[patent_title] => LOSARTAN-CONTAINING MICRO TABLET FOR PEDIATRIC APPLICATIONS
[patent_app_type] => utility
[patent_app_number] => 18/559440
[patent_app_country] => US
[patent_app_date] => 2022-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4233
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18559440
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/559440 | LOSARTAN-CONTAINING MICRO TABLET FOR PEDIATRIC APPLICATIONS | May 8, 2022 | Pending |
Array
(
[id] => 17828319
[patent_doc_number] => 20220265623
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-25
[patent_title] => AMORPHOUS KINASE INHIBITOR FORMULATIONS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/735784
[patent_app_country] => US
[patent_app_date] => 2022-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33048
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 195
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17735784
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/735784 | AMORPHOUS KINASE INHIBITOR FORMULATIONS AND METHODS OF USE THEREOF | May 2, 2022 | Abandoned |
Array
(
[id] => 17828318
[patent_doc_number] => 20220265622
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-25
[patent_title] => AMORPHOUS KINASE INHIBITOR FORMULATIONS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/735741
[patent_app_country] => US
[patent_app_date] => 2022-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33055
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 145
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17735741
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/735741 | AMORPHOUS KINASE INHIBITOR FORMULATIONS AND METHODS OF USE THEREOF | May 2, 2022 | Abandoned |
Array
(
[id] => 17775014
[patent_doc_number] => 20220241363
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-04
[patent_title] => ESSENTIAL OIL COMPOSITIONS AND APPLICATIONS UTILIZING ESSENTIAL OILS
[patent_app_type] => utility
[patent_app_number] => 17/726831
[patent_app_country] => US
[patent_app_date] => 2022-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9633
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17726831
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/726831 | ESSENTIAL OIL COMPOSITIONS AND APPLICATIONS UTILIZING ESSENTIAL OILS | Apr 21, 2022 | Pending |
Array
(
[id] => 20048099
[patent_doc_number] => 20250186321
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-06-12
[patent_title] => FORMULATION USING AMINO ACID AND CARBOXYLIC ACID, ORGANIC SALT, AND COMPOSITION COMPRISING SAME AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/286332
[patent_app_country] => US
[patent_app_date] => 2022-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36165
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -42
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18286332
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/286332 | FORMULATION USING AMINO ACID AND CARBOXYLIC ACID, ORGANIC SALT, AND COMPOSITION COMPRISING SAME AND USE THEREOF | Apr 21, 2022 | Pending |
Array
(
[id] => 18368060
[patent_doc_number] => 11648207
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-05-16
[patent_title] => Extended release pharmaceutical composition of Clozapine
[patent_app_type] => utility
[patent_app_number] => 17/716790
[patent_app_country] => US
[patent_app_date] => 2022-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7359
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 235
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17716790
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/716790 | Extended release pharmaceutical composition of Clozapine | Apr 7, 2022 | Issued |
Array
(
[id] => 17988764
[patent_doc_number] => 20220354801
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-10
[patent_title] => Multifunctional Nanoparticles For Prevention And Treatment Of Atherosclerosis
[patent_app_type] => utility
[patent_app_number] => 17/702850
[patent_app_country] => US
[patent_app_date] => 2022-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12083
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17702850
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/702850 | Multifunctional Nanoparticles For Prevention And Treatment Of Atherosclerosis | Mar 23, 2022 | Abandoned |
Array
(
[id] => 19186122
[patent_doc_number] => 20240165035
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-23
[patent_title] => COATED SOLID PHARMACEUTICAL PREPARATION
[patent_app_type] => utility
[patent_app_number] => 18/282876
[patent_app_country] => US
[patent_app_date] => 2022-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9149
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18282876
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/282876 | COATED SOLID PHARMACEUTICAL PREPARATION | Mar 17, 2022 | Pending |
Array
(
[id] => 19155935
[patent_doc_number] => 20240148641
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-09
[patent_title] => Long Acting Injectable Formulation Comprising Risperidone and Biodegradable Polymers
[patent_app_type] => utility
[patent_app_number] => 18/281392
[patent_app_country] => US
[patent_app_date] => 2022-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32428
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -48
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18281392
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/281392 | Long Acting Injectable Formulation Comprising Risperidone and Biodegradable Polymers | Mar 16, 2022 | Pending |
Array
(
[id] => 17702720
[patent_doc_number] => 20220202726
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => NEW DRY POWDER COMPOSITION FOR PERORAL ADMINISTRATION
[patent_app_type] => utility
[patent_app_number] => 17/696984
[patent_app_country] => US
[patent_app_date] => 2022-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16019
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17696984
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/696984 | Dry powder composition for peroral administration | Mar 16, 2022 | Issued |
Array
(
[id] => 19164740
[patent_doc_number] => 11980622
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-05-14
[patent_title] => Oxcarbazepine extended release dosage form
[patent_app_type] => utility
[patent_app_number] => 17/695881
[patent_app_country] => US
[patent_app_date] => 2022-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3628
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17695881
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/695881 | Oxcarbazepine extended release dosage form | Mar 15, 2022 | Issued |
Array
(
[id] => 19968482
[patent_doc_number] => 12337066
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-06-24
[patent_title] => Controlled release granulations of water-soluble active pharmaceutical ingredients
[patent_app_type] => utility
[patent_app_number] => 17/687160
[patent_app_country] => US
[patent_app_date] => 2022-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 33
[patent_no_of_words] => 18763
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 234
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17687160
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/687160 | Controlled release granulations of water-soluble active pharmaceutical ingredients | Mar 3, 2022 | Issued |
Array
(
[id] => 18149005
[patent_doc_number] => 20230022862
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => OSMOTIC DOSAGE FORMS COMPRISING DEUTETRABENAZINE AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/683732
[patent_app_country] => US
[patent_app_date] => 2022-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16709
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17683732
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/683732 | OSMOTIC DOSAGE FORMS COMPRISING DEUTETRABENAZINE AND METHODS OF USE THEREOF | Feb 28, 2022 | Abandoned |
Array
(
[id] => 19096282
[patent_doc_number] => 20240115509
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-11
[patent_title] => A PROBIOTIC GRANULE HAVING A UNIFIED STABILIZING COATING AND A METHOD FOR THE PRODUCTION THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/276464
[patent_app_country] => US
[patent_app_date] => 2022-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20655
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18276464
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/276464 | A PROBIOTIC GRANULE HAVING A UNIFIED STABILIZING COATING AND A METHOD FOR THE PRODUCTION THEREOF | Feb 9, 2022 | Pending |
Array
(
[id] => 19157999
[patent_doc_number] => 20240150706
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-09
[patent_title] => FORMULATIONS OF MICROENCAPSULATED MICROBIAL CULTURE WITH HIGH STORAGE STABILITY
[patent_app_type] => utility
[patent_app_number] => 18/264954
[patent_app_country] => US
[patent_app_date] => 2022-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13826
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18264954
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/264954 | FORMULATIONS OF MICROENCAPSULATED MICROBIAL CULTURE WITH HIGH STORAGE STABILITY | Feb 9, 2022 | Pending |
Array
(
[id] => 17609659
[patent_doc_number] => 20220151938
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-19
[patent_title] => TABLET FOR USE IN TREATING HUNTINGTON'S DISEASE AND METHOD OF MAKING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/588206
[patent_app_country] => US
[patent_app_date] => 2022-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27028
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 157
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17588206
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/588206 | TABLET FOR USE IN TREATING HUNTINGTON'S DISEASE AND METHOD OF MAKING THE SAME | Jan 27, 2022 | Abandoned |
Array
(
[id] => 19430799
[patent_doc_number] => 20240299297
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-12
[patent_title] => STABLE EMULSIONS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 18/273732
[patent_app_country] => US
[patent_app_date] => 2022-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35469
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18273732
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/273732 | STABLE EMULSIONS AND METHODS | Jan 26, 2022 | Pending |
Array
(
[id] => 17759920
[patent_doc_number] => 20220233532
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-28
[patent_title] => FAST DISSOLVING PHARMACEUTICAL COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/580768
[patent_app_country] => US
[patent_app_date] => 2022-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18954
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17580768
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/580768 | Fast dissolving pharmaceutical compositions | Jan 20, 2022 | Issued |
Array
(
[id] => 17655232
[patent_doc_number] => 20220175697
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-09
[patent_title] => COMPOSITIONS AND METHODS OF TREATING AGE-RELATED MACULAR DEGENERATION
[patent_app_type] => utility
[patent_app_number] => 17/574705
[patent_app_country] => US
[patent_app_date] => 2022-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8443
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17574705
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/574705 | Compositions and methods of treating age-related macular degeneration | Jan 12, 2022 | Issued |
Array
(
[id] => 17655425
[patent_doc_number] => 20220175890
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-09
[patent_title] => THERAPEUTIC AGENT PREPARATIONS FOR DELIVERY INTO A LUMEN OF THE INTESTINAL TRACT USING A SWALLOWABLE DRUG DELIVERY DEVICE
[patent_app_type] => utility
[patent_app_number] => 17/552325
[patent_app_country] => US
[patent_app_date] => 2021-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23183
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17552325
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/552325 | THERAPEUTIC AGENT PREPARATIONS FOR DELIVERY INTO A LUMEN OF THE INTESTINAL TRACT USING A SWALLOWABLE DRUG DELIVERY DEVICE | Dec 14, 2021 | Abandoned |